Log in or Sign up for Free to view tailored content for your specialty!
Lung Cancer News
FDA approves tremelimumab regimen for metastatic non-small cell lung cancer
The FDA approved tremelimumab in combination with durvalumab and platinum-based chemotherapy for certain patients with metastatic non-small cell lung cancer.
FDA approves Libtayo with chemotherapy for advanced non-small cell lung cancer
The FDA approved cemiplimab-rwlc in combination with platinum-based chemotherapy for first-line treatment of advanced non-small cell lung cancer.
Log in or Sign up for Free to view tailored content for your specialty!
Factors predict compliance with payer-led oncology clinical pathways
A study presented at this year’s ASCO Quality Care Symposium examined predictors of compliance with payer-led oncology clinical pathways.
Psilocybin studies may lead to ‘revolutionary’ shift in cancer-related depression treatment
For centuries, psychedelic plants and fungi have been harvested and explored for medicinal purposes.
Organizations issue call to action to increase lung cancer screening for high-risk adults
Significant action is necessary to prioritize early detection of lung cancer through expanded screening for high-risk individuals, according to a consensus statement released today.
U.S. cancer death rates continue to drop as incidence remains stable
Cancer death rates declined broadly between 2015 and 2019 in the United States as overall incidence remained generally stable, according to the Annual Report to the Nation on the Status of Cancer.
Immune checkpoint inhibitor cancer therapy increases risk for sarcoidosis
NASHVILLE, Tenn. — Patients who received immune checkpoint inhibitor therapy may have a greater risk for sarcoidosis, according to study results presented at CHEST Annual Meeting.
Machine-learning approach using step counts predicts hospitalization during radiotherapy
An artificial intelligence model appeared to predict the likelihood of unplanned hospitalizations during chemoradiation therapy among a cohort of patients with various cancer types.
Increased radiation dose after missed treatments may benefit some patients with NSCLC
Some patients with non-small cell lung cancer who miss radiation treatments may benefit from higher radiation doses, according to a study presented at American Society for Radiation Oncology (ASTRO) Annual Meeting.
Lung cancer survivors may benefit from screenings for cardiovascular risk, substance abuse
NASHVILLE, Tenn. — Lung cancer survivors had similar or increased frequency of and risk for cardiovascular comorbidities and substance abuse than patients with active lung cancer, according to a presenter at the CHEST Annual Meeting.